- Home
- PCVX vs DNP Comparison
PCVX vs DNP Comparison
Compare PCVX & DNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- DNP
- Stock Information
- Founded
- PCVX 2013
- DNP 1986
- Country
- PCVX United States
- DNP United States
- Employees
- PCVX N/A
- DNP N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- DNP Investment Managers
- Sector
- PCVX Health Care
- DNP Finance
- Exchange
- PCVX Nasdaq
- DNP Nasdaq
- Market Cap
- PCVX 4.0B
- DNP 3.8B
- IPO Year
- PCVX 2020
- DNP N/A
- Fundamental
- Price
- PCVX $45.16
- DNP $10.18
- Analyst Decision
- PCVX Strong Buy
- DNP
- Analyst Count
- PCVX 7
- DNP 0
- Target Price
- PCVX $101.67
- DNP N/A
- AVG Volume (30 Days)
- PCVX 1.4M
- DNP 479.6K
- Earning Date
- PCVX 11-04-2025
- DNP 01-01-0001
- Dividend Yield
- PCVX N/A
- DNP 7.88%
- EPS Growth
- PCVX N/A
- DNP N/A
- EPS
- PCVX N/A
- DNP 2.30
- Revenue
- PCVX N/A
- DNP $154,887,179.00
- Revenue This Year
- PCVX N/A
- DNP N/A
- Revenue Next Year
- PCVX N/A
- DNP N/A
- P/E Ratio
- PCVX N/A
- DNP $4.26
- Revenue Growth
- PCVX N/A
- DNP 3.30
- 52 Week Low
- PCVX $27.66
- DNP $8.69
- 52 Week High
- PCVX $107.22
- DNP $10.04
- Technical
- Relative Strength Index (RSI)
- PCVX 61.06
- DNP 57.16
- Support Level
- PCVX $40.14
- DNP $9.96
- Resistance Level
- PCVX $45.90
- DNP $10.22
- Average True Range (ATR)
- PCVX 2.15
- DNP 0.10
- MACD
- PCVX -0.13
- DNP 0.00
- Stochastic Oscillator
- PCVX 84.87
- DNP 75.66
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About DNP DNP Select Income Fund Inc.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.